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Core histones can be modified by reversible, posttranslational acetylation of specific lysine residues within the N-terminal protein domains. The 
dynamic equilibrium of acetylation is maintained by two enzyme activities, histone acetyltransferase and histone deacetylase. Recent data on histone 
deacetylases and on anionic motifs in chromatin- or DNA-binding regulatory proteins (e.g. transcription factors, nuclear proto-oncogenes) are 
summarized and united into a hypothesis which attributes a key function to histone deacetylation for the binding of regulatory proteins to chromatin 
by a transient, specific local increase of the positive charge in the N-terminal domains of nucleosomal core histones. According to our model, the 
rapid deacetylation of distinct lysines in especially H2A and H2B would facilitate the association of anionic protein domains of regulatory proteins 
to specific nucleosomes. Therefore histone deacetylation (histone deacetylases) may represent a unique regulatory mechanism in the early steps 
of gene activation, in contrast to the more structural role of histone acetylation (histone acetyltransferases) for nucleosomal transitions during the 
actual transcription process. 
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1. INTRODUCTION 
The DNA of the eukaryotic cell nucleus is associated 
with histones to form nucleosomes, which represent he 
basic structural subunit of chromatin [l]. Histones can 
be reversibly modified by a number of posttranslational 
reactions, such as phosphorylation, acetylation, ADP- 
ribosylation and ubiquitination (see [2] for a recent re- 
view). The posttranslational acetylation of lysine resi- 
dues within the N-terminal domains of core histones 
was first discovered by Allfrey and co-workers [3] and 
is assumed to play a critical role in the modulation of 
structural transitions of chromatin during different nu- 
clear processes [2,4-81, although the precise mecha- 
nisms are still far from clear. 
The dynamic state of histone acetylation is main- 
tained by two enzyme activities, histone acetyltrans- 
ferase and histone deacetylase. Histone acetyltrans- 
ferases link the acetyl-moiety of acetyl-CoA to the 
E-amino group of specific lysine residues. The presence 
of such an acetyl-group neutralizes a positive charge 
within the N-terminal part of the histone molecule (Fig. 
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1). This modification can be reversed by the action of 
deacetylases. The amino acid sequence of the N-termi- 
nal histone tails has been conserved during evolution; 
therefore the lysine positions which are accessible to this 
enzymatic acetylation are identical in a wide variety of 
organisms ranging from yeast to human. There are 26 
28 possible acetylation sites within a nucleosome [4]; it 
has to be considered that these sites are concentrated on 
relatively small, but flexible protein domains of the nu- 
cleosome (Fig.1). The usage of these lysine residues for 
acetyltransferases has been shown to occur in a non- 
random fashion, thus generating a further level of com- 
plexity, although the extent of site specificity may be 
different among various organisms [9-141. 
It was proposed that histone acetylation represents a 
general mechanism for the destabilization of nucleo- 
somes [5,15]. Such a transient destabilization has to 
occur during nuclear processes that are accompanied by 
structural transitions of defined chromatin areas, i.e. 
DNA replication, transcription, DNA repair, recombi- 
nation or differentiation specific exchange of histone 
variants. The site specificity, the high variability in the 
extent of acetylation, and the multiplicity of enzymes 
involved in this modification, would finally lead to 
highly specific acetylation patterns which serve as dis- 
tinct signals for nucleosome destabilization in different 
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Fig. 1. Schematic drawing of the nucleosome core. The nucleosome 
core particle consists of two molecules of each of the core histones 
H2A, H2B, H3 and H4 and approx. 160 bp of DNA. H3 and H4 form 
a tetramer which binds two H2A/H2B dimers. The N-terminal histone 
domains contain a total of 28 lysine residues which undergo posttrans- 
lational acetylation and deacetylation. The diagram depicts the H3/H4 
tetramer in its maximum acetylated form, the two H2A/H2B dimers 
in its deacetylated configuration. 
nuclear processes. A central point of the previous pro- 
posal was that acetylation of all histones, but especially 
H3 and H4, would be a prerequisite for the nucleosomal 
structural transitions concomitant with DNA replica- 
tion and exchange of histone primary structure variants 
in differentiation, whereas specific acetylation of H2A 
and H2B would be required for the destabilization of 
nucleosomes during transcription [5]. Since the original 
proposal, sound experimental evidence has accumu- 
lated, indicating that transient H2A/H2B deficiency ac- 
companies transcriptional initiation and elongation 
[16-211. For the transcription of the ribosomal genes of 
Physarum it has been recently shown in vivo. that ac- 
tively transcribed gene fragments are devoid of H2A 
and H2B, whereas non-transcribed regions have the 
normal histone complement [22]. In accord with the 
proposed role of histone acetylation during transcrip- 
tion it could be demonstrated that the acetylation of H3 
and H4 did not differ between actively transcribed and 
non-transcribed ribosomal gene chromatin [22]. How- 
ever, contradictory results have been published indicat- 
ing an involvement of H3 and H4 acetylation in the 
active transcription of genes [23]. Moreover, a direct 
link between the extent of H4 acetylation and transcrip- 
tion was shown, using an immunological approach [24]. 
The reason for the apparent discrepancies is still not 
understood, although we suppose that histone acetyla- 
tion may contribute at different levels during the activa- 
tion and transcription of genes. Recent data [25] argue 
against the involvement of H3 acetylation in transcrip- 
tional activation, since both, deletions and acetylation 
site substitutions within the N-terminus of H3 allowed 
hyperactivation of the GAL1 promotor as well as a 
number of GALCregulated genes in yeast. In contrast, 
the N-terminal sequence of H4 is required for promotor 
activation in vivo; mutations in H4 acetylation sites 
reduced the activation of the GAL1 and PH05 promo- 
tor in yeast [26]. However, GAL1 and PH05 contain 
positioned nucleosomes within their promotors. 
whereas GAL4 as a constitutive gene, is probably not 
tightly packed in nucleosomes [26]. The different dis- 
pensibility of acetylated sites among the N-termini of 
H3 and H4 indicates that the functional impact of his- 
tone acetylation is complex and maybe entirely different 
in the individual histone species. 
An alternative approach to a better understanding of 
the function of histone acetylation is the investigation 
of the enzymes involved in the dynamic equilibrium of 
this modification, histone acetyltransferases and deace- 
tylases. Acetyltransferases can be classified with respect 
to their intracellular location and substrate specificity 
into nuclear A-type and cytoplasmic B-type enzymes. 
Extensive investigations of the substrate specificity of 
histone acetyltransferases in yeast, pea, maize and Phy- 
sarum have revealed that H3 and H4 are the predomi- 
nant substrate molecules for these enzymes [27-311. 
whereas H2A and H2B only represent minor substrates, 
although multiple enzymes or enzyme forms exist. On 
the other hand, analysis of the substrate specificity of 
histone deacetylases, using HPLC purified, radioac- 
tively pre-labelled, individual core histone species, re- 
vealed an overproportional affinity of these enzymes for 
H2A and H2B [30,32,33]. This indicates that the regula- 
tion of H2A and H2B acetylation could preferentially 
occur on the level of deacetylation. Moreover, the oc- 
curance of multiple deacetylases suggests a key role for 
histone deacetylases in establishing and maintaining 
certain properties of eukaryotic chromatin. 
2. HISTONE DEACETYLASES 
Histone deacetylases have been most extensively 
studied in plant cells [29,33,34]. In maize embryos three 
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distinct enzymes are present; HDl A, HDlB and HD2, 
which differ in their substrate specificity. The substrate 
specificity of HDlA is furthermore regulated by revers- 
ible phosphorylation, giving rise to a number of 
phosphorylated enzyme forms [32]. HD2 is differentia- 
tion specific, since it represents the main deacetylase 
activity in dormant embryos, but disappears during 
progression of germination [35]. It was suggested that 
HD2 has an essential function in DNA repair, since its 
activity pattern closely resembles the course of repair 
synthesis during the early germination of maize em- 
bryos. 
The fact that histone deacetylase HDlA is 
phosphorylated and as a consequence xhibits a dra- 
matic shift in its substrate specificity [32], provides evi- 
dence that this enzyme could be involved in cellular 
signal transduction pathways. Together with the finding 
that the enzyme has a high substrate preference for 
H2B, and phosphorylation causes a dramatic increase 
of the affinity for H2A, we propose that histone deace- 
tylases can be specifically involved in the early tran- 
scriptional activation of genes. 
3. HYPOTHESIS 
One of the most challenging problems of molecular 
biology is the understanding of how genes are activated 
from a repressed into an actively transcribed state. A 
great number of proteins, that are either localized in the 
nucleus or exert their regulatory function in the nucleus 
by DNA- or chromatin binding, possess stretches of 
acidic amino acids (anionic domains), apart from other 
distinct structural motifs. Such anionic regions are 
much more common in nuclear than cytoplasmic pro- 
teins. Among these nuclear proteins are enzymes (e.g. 
DNA polymerase, topoisomerase [36,37]), nucleoplas- 
min [38], HMG-proteins [39], chromosomal and nuclear 
matrix proteins [40,41], nuclear proto-oncogene pro- 
teins and tumor suppressor gene products (e.g. c-myc, 
c-jun, p53 [42-44]) and transcription factors [4548]. As 
already pointed out by Earnshaw [49] it is conceivable 
that the binding onto chromatin of regulatory proteins 
or enzymes with anionic regions, or the association of 
distinct DNA regions with anionic motifs of structural 
proteins could be modulated by the acetylation of N- 
terminal core histone domains. If such proteins come 
into contact with the protein part of nucleosomes, it is 
unlikely that contact sites are located within the globu- 
lar histone domains, which are mostly inaccessible due 
to the DNA wrapped around this globular core. The 
much more probable contact location are the short, but 
flexible N-terminal parts, especially of H2A and H2B. 
Since these N-terminal tails contain a cluster of acetyl- 
ated lysine residues, a transient, yet highly specific de- 
acetylation would facilitate the molecular contact with 
anionic protein domains (Fig. 2). 
The action of a specific histone deacetylase will rap- 
/ 
deacetylsted area 
N-terminal core 
hlstone domains 
histone cctamer 
hlstone deacetylase 
- DNA 
_- 
0 
-_ aniomc domain of 
-i 
regulatory protem 
DNA bmdmg site of 
regulatory protern 
Fig. 2. Hypothetical role of histone deacetylase for the binding of 
regulatory proteins to chromatin. A specific histone deacetylase tran- 
siently deacetylates N-terminal lysine residues of especially H2A and 
H2B in a distinct chromatin area. This leads to a hotspot of positive 
charge in only few nucleosomes without pronounced structural 
changes of the overall chromatin structure. The anionic region of 
regulatory proteins (transcription factors, proto-oncogene proteins), 
enzymes, but also structural proteins (nuclear matrix components) can 
then establish a contact that enables the DNA recognition site to bind. 
Due to the higher-order folding of chromatin. the anionic contact site 
and the DNA recognition site may be several nucleosomes apart. 
idly increase the net positive charge of the N-terminal 
domains. The specific deacetylation of these sites within 
a very small chromatin area would enable the associa- 
tion of anionic regions of regulatory proteins or tran- 
scription factors. This binding could occur concomitant 
with a sequence specific recognition of DNA-sites by 
regulatory proteins and therefore represent one of the 
first steps in the gene activation cascade. Since regula- 
tory proteins may activate chromatin from a silent, 
rather condensed structural state, the model allows the 
binding or stabilization of regulatory proteins via chro- 
matin binding domains at positions upstream or down- 
stream of a sequence specific DNA recognition site, due 
to higher order structures. Analysis of histone acetyla- 
tion in chicken globin gene switching revealed highly 
acetylated histones in both, the transcriptionally active 
and inactive, but ‘poised’ gene [50]. Both transcription- 
ally active and inactive parts of the ribosomal gene 
chromatin of Physarum contained highly acetylated 
core histones [22]. These data demonstrate that ‘poised’, 
but even transcriptionally inactive genes, may at least 
partially contain acetylated histone subspecies. There- 
fore, a specific histone deacetylase would be able to 
generate additional positive charge in specific areas of 
such chromatin. 
According to our proposal, H2A and H2B, apart 
from being minor substrates for histone acetyltrans- 
ferases, have to be rapidly deacetylated by a specific 
histone deacetylase when early transcriptional activa- 
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tion occurs. Our recent finding of HDlA phosphoryla- 
tion with the resulting increase in H2A specificity sug- 
gests that identical pathways of intracellular signal 
transduction, which are generally involved in the activa- 
tion of genes, could regulate the substrate specificity of 
the deacetylase via phosphorylation/dephosphorylation 
mechanisms. We postulate that a transient H2A and 
H2B deacetylation is required for the binding of regula- 
tory proteins, e.g. transcription factors, to nucleosomal 
structures at an early step of gene activation. Our pro- 
posal is compatible with the site-specific acetylation of 
H2A and H2B necessary for transcription [5]. 
The time course from activation of a repressed gene 
to the active transcription by RNA polymerase involves 
a cascade of different events. At least two distant steps 
can be defined: (i) The binding of regulatory proteins to 
a chromatin domain, as the initial step of activation 
which would require the rapid, local deacetylation of 
core histones, in particular H2A and H2B. (ii) The de- 
stabilization of the nucleosome and the removal of 
H2A/ H2B dimers in a progressive displacement mode 
[5.17,18,51] as the final step of activation. This final 
displacement can be dependent on the site specific ace- 
tylation of H2A and H2B. We propose that chromatin 
structural transitions necessary for transcription also 
occur on a different level, e.g. on the level of acetylation 
of H3 and H4. However, acetylation of core histones by 
the action of histone acetyltransferases. leading to ac- 
tual changes in the structural stability of nucleosomes 
[5], is distinguished from the specific role of transient 
deacetylation at the initial phase of gene activation. For 
this reason, our model attributes a regulatory function 
to histone deacetylation (= histone deacetylases) in the 
early transcriptional activation of genes, but a more 
structural role to histone acetylation (=histone ace- 
tyltransferases) in actual changes of the nucleosome 
structure at the final stage of the transcriptional activa- 
tion (e.g. the removal of H2A/H2B dimers). 
4. EVIDENCES, PERSPECTIVES 
A number of recent observations on transcriptional 
activation and the intranuclear localization of regula- 
tory proteins can be explained in terms of our model. 
It has been shown that the glucocorticoid receptor-me- 
diated activation of mouse mammary tumor virus long 
terminal repeat fusion genes is strongly inhibited by 
sodium butyrate, a non-competitive inhibitor of animal 
and fungal histone deacetylases. Inhibition of the deace- 
tylation reaction in this case caused the inhibition of the 
activation of transcription [52,53]. 
We have recently demonstrated that the nuclear lo- 
calization of the c-myc protein, a protein with anionic 
domains, is dramatically affected by in vivo inhibition 
of histone deacetylase by butyrate (1 mM) in the 
myxomycete Physarum polycephaium [54,55]; the c-myc 
protein is associated with the nuclear matrix in a cell 
178 
cycle dependent way [54]. In contrast to a number of 
other compounds tested, only butyrate completely abol- 
ished this specific association [55] without affecting the 
amount of this protein in the nuclei. In parallel butyrate 
leads to a distinct change of the acetylation pattern of 
the nuclear matrix bound core histones (Loidl, unpub- 
lished results). This finding presents circumstantial evi- 
dence that inhibition of histone deacetylation interferes 
with the correct binding of a DNA binding protein to 
a nuclear substructure. 
For almost two decades n-butyrate was used as an 
experimental tool in the investigation of histone acetyl- 
ation and its effects on chromatin structure and func- 
tion. Apart from its inhibitory effect on histone deace- 
tylases, this compound has been used as an inducer of 
cellular differentiation [56]. Recently, it has been shown 
that another substance, the antibiotic Trichostatin A, is 
a highly specific inhibitor (K, 3.4 nM) of mammalian 
histone deacetylase [57]; strikingly Trichostatin is also 
a potent inducer of Friend cell differentiation [58]. 
These results again indicate the possibility that the spe- 
cific inhibition of deacetylation may contribute to cellu- 
lar reorganization. 
It has been recently demonstrated that butyrate and 
Trichostatin inhibit the transcriptional activation func- 
tion of MyoD and myogenin in proliferating myoblasts 
and differentiated myotubes [59], although the in vitro 
DNA binding ability remained unaffected. The authors 
explained this loss of transcriptional activation with the 
inhibition of histone deacetylase and the resulting 
change in the acetylation pattern of nucleosomes. In 
human breast cancer cells low concentrations of bu- 
tyrate lead to reduced prolactin receptor gene expres- 
sion; this inhibition was independent of ongoing protein 
synthesis and not due to an alteration of prolactin re- 
ceptor mRNA half-life [60]. Our model would account 
for such an effect. 
For the regulatory gene areA, which mediates nitro- 
gen metabolite repression in Aspergillus nidulans, it has 
been shown that only mutations in the zinc finger do- 
main and in the acidic region resulted in a loss of gene 
activation, thus confirming that anionic domains are 
indispensible for gene regulation [61]. 
Our current view of chromatin organization in gen- 
eral attributes an inhibitory function to nucleosomes for 
processes like DNA replication [62] and transcription 
[51,63,64]. For this reason one favours mechanistic 
ideas to explain the disintegration or transient removal 
of nucleosomes which results in the most accessible 
form of genetic information-free DNA. However, re- 
cently a first example of the opposite mechanism has 
been presented: nucleosomes and the correct chromatin 
assembly act as positive elements for retroviral integra- 
tion site selection [65,66]. It was shown that the retrovi- 
ral integration machinery prefers distinct target sites 
within nucleosomes, but not at all nucleosome-free 
DNA. Since nucleosomes are a uniform and invariable 
Volume 317. number 3 FEBS LETTERS 
structural unit, the best candidates for modulating their 
properties are changes in the N-terminal histone do- 
mains. It is widely accepted that the acetylation of the 
N-terminal lysines of core histones plays an important 
role for chromatin structure and function. However, we 
propose that the specific deacetylation and therefore the 
focused increase of the net positive charge of the nucle- 
osome could play an equally powerful role in determin- 
ing the properties of nucleosomes by a specific modifi- 
cation of contact sites for the binding of regulatory 
proteins, enzymes and structural elements, especially in 
the gene activation mechanism. 
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